Article info
PDFNeurodegeneration
Review
Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions
- Correspondence to Dr Nadia Magdalinou, Reta Lila Weston Institute, UCL Institute of Neurology, 1 Wakefiled Street, London WC1N 1PJ, UK; n.magdalinou{at}ucl.ac.uk
Citation
Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions
Publication history
- Received January 3, 2014
- Revised February 17, 2014
- Accepted February 24, 2014
- First published April 1, 2014.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/